From solid tumors to metastatic carcinomas and leukemia: cancer is among the most common causes of death and has many faces. Keep reading for latest developments in early detection, staging, therapy and research.
After 15 years of HPV vaccination programmes across Europe, growing evidence confirms their long-term effectiveness. A new report highlights steady progress in cancer prevention efforts.
Researchers have taken an early but promising step toward a cancer therapy that targets and destroys tumor cells with high precision, using a variant of the DNA editing tool CRISPR.
For a young adult, a cancer diagnosis hits different: a more aggressive disease course, greater disruptive potential, longer survivorship. Yet most healthcare institutions seem poorly prepared for this growing patient group. A plenary session at the NCCN 2026 Annual Conference examined a striking shift in modern oncology: the rising incidence of cancer in adolescents and young adults (AYA).
AI models can generate more complete summaries of complex cancer pathology reports than physicians, according to a new study that tested six models developed by Meta, Google, DeepSeek and Mistral AI.
To improve lung cancer detection, researchers have developed a new AI system that employs a dual approach to analyse CT scans – seeing both detail and context at the same time.
Patient-derived organoids (PDOs), or tumoroids, for pediatric brain cancer show promise in helping researchers find new drugs and better understand the different responses of the tumor.
A new scientific study reveals a strong link between exposure to agricultural pesticides in the environment and the risk of developing cancer on a national scale.
Earlier detection, better outcomes: A new blood test for bowel cancer screening is designed to transform cancer outcomes by moving away from invasive or unpleasant methods.
A new review shows that chronic stress may actively drive cancer progression. Therefore, psycho-oncology should be part of standard cancer care, the researchers argue.
Fear that their cancer will progress or worsen is one of the most common concerns among people living with this disease. A new tool aims to reliably measure patients’ anxiety about their cancer.
Two new studies explore the role of the thymus – a small organ in the chest, and possibly a missing piece in explaining why people age differently, and why cancer treatments fail in some patients.
Why do some cancer cells develop treatment resistance? The answer may lie in hidden “storage hubs” inside tumour cells, which create uneven drug exposure across tumours, according to new research.
Women are more likely to survive cancer than men but face a higher risk of serious and adverse side effects from treatment, according to a new international study.
Glioblastoma is notorious for late diagnosis, rapid progression, resistance to treatment and its biological complexity. A new experimental method could help detect this deadly type of brain cancer.
Researchers discovered that pineoblastoma, retinoblastoma and medulloblastoma – severe brain tumours in children that appear to be completely different – actually arise from the same type of cell.
Researchers have discovered a new way to protect the heart during cancer chemotherapy without reducing antitumor efficacy. This could reduce long-term cardiovascular complications for patients.
Radiation oncology is a field in remarkable transformation: a deepening global shortage of trained practitioners, persistent inequities in access to treatment – and, on the other side of the ledger, a new generation of technologies, from AI-driven adaptive planning to photon-counting CT, that are expanding what the field can do in ways previously unimaginable. At this year’s World Health Expo…
Pancreatic cancer remains a diagnostic challenge, due to unspecific early symptoms and lack of effective screening tools. A novel AI metabolomics platform could help overcome these issues.
Vaccination against human papillomavirus (HPV) reduces the risk of cervical cancer for at least 18 years, according to a new study. There were no signs of waning protection over time.
